Bridgeway Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-36,600
| Closed | -$139K | – | 1428 |
|
|
2019
Q3 | $139K | Buy |
+36,600
| New | +$139K | ﹤0.01% | 1220 |
|
|
2018
Q4 | – | Sell |
-19,868
| Closed | -$392K | – | 1506 |
|
|
2018
Q3 | $392K | Hold |
19,868
| – | – | ﹤0.01% | 1196 |
|
|
2018
Q2 | $631K | Buy |
19,868
+12,020
| +153% | +$382K | 0.01% | 1059 |
|
|
2018
Q1 | $290K | Sell |
7,848
-7,780
| -50% | -$287K | ﹤0.01% | 1212 |
|
|
2017
Q4 | $1.24M | Buy |
+15,628
| New | +$1.24M | 0.01% | 761 |
|